English
Home > Products > CAS NO 26787-78-0

China CAS NO 26787-78-0 Factory

"Based on domestic market and expand abroad business" is our enhancement strategy for CAS NO 26787-78-0,26787-78-0,Amoxicillin API,Amoxicillin, We welcome all with the shoppers and buddies to call us for mutual rewards. Hope to do further more business along with you.
CAS NO 26787-78-0, With the spirit of "credit first, development through innovation, sincere cooperation and joint growth", our company is striving to create a brilliant future with you, so as to become a most valuable platform for exporting our products in China!

Related Products

Hot Products

  • Oclacitinib maleate

    Oclacitinib maleate

    Product Name:Oclacitinib maleate
    Molecular Formula:C19H27N5O6S
    Molecular Weight;453.51258
    CAS Registry Number;1640292-55-2
  • Oxiracetam

    Oxiracetam

    Product Name:Oxiracetam
    Molecular Formula:C6H10N2O3
    Molecular Weight;158.16
    CAS Registry Number;62613-82-5
  • Tilmicosin

    Tilmicosin

    Product Name:Tilmicosin
    Molecular Formula:C46H80N2O13
    Molecular Weight;869.15
    CAS Registry Number;108050-54-0
  • (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one

    (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one

    Product Name:(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one
    Molecular Formula:C31H25F2NO3
    Molecular Weight:497.53
    CAS Registry Number:190595-65-4
  • LeterMovir

    LeterMovir

    Product Name:LeterMovir
    Molecular Formula:C29H28F4N4O4
    Molecular Weight;572.55
    CAS Registry Number;917389-32-3
  • (3-Chloropyrazin-2-yl)MethanaMine hydrochloride

    (3-Chloropyrazin-2-yl)MethanaMine hydrochloride

    Product Name:(3-Chloropyrazin-2-yl)MethanaMine hydrochloride
    Molecular Formula:C5H7Cl2N3
    Molecular Weight:180.03
    CAS Registry Number:939412-86-9
  • Related Blog
  • Reviews

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept